These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18092829)

  • 1. Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors.
    Braun GH; Jorge DM; Ramos HP; Alves RM; da Silva VB; Giuliatti S; Sampaio SV; Taft CA; Silva CH
    J Biomol Struct Dyn; 2008 Feb; 25(4):347-55. PubMed ID: 18092829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.
    Yelekçi K; Karahan O; Toprakçi M
    J Neural Transm (Vienna); 2007; 114(6):725-32. PubMed ID: 17401533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
    Toprakçí M; Yelekçi K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4438-46. PubMed ID: 16137882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
    Ramsay RR
    Vopr Med Khim; 1997; 43(6):457-70. PubMed ID: 9503563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors.
    Prins LH; Petzer JP; Malan SF
    Bioorg Med Chem; 2009 Nov; 17(21):7523-30. PubMed ID: 19804982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
    J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease.
    Weinreb O; Amit T; Riederer P; Youdim MB; Mandel SA
    Int Rev Neurobiol; 2011; 100():127-49. PubMed ID: 21971006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and analysis of MAO-B inhibitors for Parkinson's disease: using in silico approaches.
    Kare P; Bhat J; Sobhia ME
    Mol Divers; 2013 Feb; 17(1):111-22. PubMed ID: 23325357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indanones as high-potency reversible inhibitors of monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.